Following a PCE Symposia Live Stream Series, an expert in infectious diseases and influenza gives his personal perspectives on influenza treatment and post-exposure chemoprophylaxis strategies in immunosuppressed adults and children including optimal use of neuraminidase inhibitors (NAIs) and baloxavir.
Physicians, NPs, and PAs practicing in rheumatology or oncology
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Auwaerter: consulting fees: EMD Serono, Verily; contracted research: Humanigen; other financial or material support: Johnson & Johnson.
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102121FCT2